Literature DB >> 1889700

Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis.

K N Ekdahl1, L Lööf, A Nyberg, U R Nilsson, B Nilsson.   

Abstract

Fc receptor-mediated clearance of immunoglobulin G-coated autologous erythrocytes was studied in patients with primary biliary cirrhosis (n = 14), alcoholic liver cirrhosis (n = 5) and healthy reference individuals (n = 14). The mean half-life of the sensitized erythrocytes was significantly prolonged in patients with primary biliary cirrhosis (85 +/- 25 minutes; P less than 0.001) compared with the corresponding value in patients with alcoholic cirrhosis (16 +/- 2 minutes) and healthy reference individuals (20 +/- 5 minutes), respectively. No correlation between clearance rate and age, liver histopathology, or serum levels of bilirubin, aminotransferases, immunoglobulin G, immunoglobulin A, and Clq binding or C3-containing immune complexes was found. The results presented here indicate a profound disturbance of Fc receptor-mediated immune clearance function in patients with primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889700     DOI: 10.1016/0016-5085(91)90736-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  4 in total

1.  T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.

Authors:  Jorge Allina; Bin Hu; Daniel M Sullivan; Maria Isabel Fiel; Swan N Thung; Steven F Bronk; Robert C Huebert; Judy van de Water; Nicholas F LaRusso; M E Gershwin; Gregory J Gores; Joseph A Odin
Journal:  J Autoimmun       Date:  2007-01-10       Impact factor: 7.094

2.  Impairments in complement receptor- and Fc receptor-mediated functions in vivo in patients with psoriasis.

Authors:  K N Ekdahl; G Michaëlsson; B Gerdén; L Lööf; B Nilsson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

3.  Reconstitution of the alternative pathway of complement by plasma infusions given to a patient with an SLE-like syndrome associated with a hereditary C3 dysfunction.

Authors:  B Nilsson; U R Nilsson; A Karlsson-Parra; G Sjölin-Forsberg; R Hällgren
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

Review 4.  Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response.

Authors:  Bridget P Keenan; Lawrence Fong; Robin K Kelley
Journal:  J Immunother Cancer       Date:  2019-10-18       Impact factor: 13.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.